Saffron Supplementation for Stargardt Disease: Italy
Description: The Catholic University of the Sacred Heart in Italy is conducting a 30-person clinical trial of saffron for the treatment of Stargardt disease. Saffron contains high concentrations of crocin and crocetin, compounds with anti-oxidative properties. Saffron supplementation has inhibited retinal degeneration in lab studies.
Trial Status: Recruiting participants.
Partial List of Participation Criteria:
- 8 to 60 years of age
- Retina appears to be affected by Stargardt disease
Clinical Trial Contact:
Benedetto Falsini, M.D.
Phone: 0039063015 ext. 4929
Policlinico A. Gemelli
Saffron supplementation clinical trial for Stargardt disease listing on ClinicalTrials.gov